FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth Biotechnologies) is a global biologics CDMO operating 10 facilities across the US, UK, Denmark, and Japan with over 4,800 employees. The company provides end-to-end cGMP manufacturing services for biologics, advanced therapies, and vaccines, from preclinical through commercialization, with $8.6 billion invested in recent years and 20+ commercial licenses.
Biologics CDMO, mammalian cell culture, microbial fermentation, cell and gene therapy, vaccine manufacturing, viral vectors
4 sites worldwide
No certifications on file yet.
No reviews available yet.
No documents available.